I-bodies: human single domain antibodies that antagonize chemokine receptor CXCR4

I-bodies: human single domain antibodies that antagonize chemokine receptor CXCR4GPCR Target: CXCR4Authors: Katherine Griffithsa, et al.Company: Dept. of Biochemistry, La Trobe University, Australia.Journal: JBC Journal of Biological Chemestry. April 1,…

Continue ReadingI-bodies: human single domain antibodies that antagonize chemokine receptor CXCR4

GPR37 Surface Expression Enhancement via N-Terminal Truncation or Protein-Protein Interactions

GPR37 Surface Expression Enhancement via N-Terminal Truncation or Protein-Protein InteractionsGPCR Target: GPR37L1 Authors: Jill H. Dunham, et al.Company: Department of Pharmacology, Emory University School of Medicine, Atlanta, GeorgiaJournal: Biochemistry 2009, 48,…

Continue ReadingGPR37 Surface Expression Enhancement via N-Terminal Truncation or Protein-Protein Interactions

A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models

A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal modelsGPCR Target: S1P1Authors: Jing Jin et al.Company: Institute of Materia Medica, Chinese Academy of Medical SciencesJournal: Acta Pharmaceutica Sinica B…

Continue ReadingA novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models

The N-terminus of GPR37L1 is proteolytically processed by matrix metalloproteases

The N-terminus of GPR37L1 is proteolytically processed by matrix metalloproteasesGPCR Target: GPR37L1Authors: James L. J. Coleman, et al.Company: Molecular Cardiology & Biophysics Division, Victor Chang Cardiac Research Institute, Darlinghurst, AustraliaJournal:…

Continue ReadingThe N-terminus of GPR37L1 is proteolytically processed by matrix metalloproteases

In Vitro Pharmacological Profile of a New Small Molecule Bradykinin B2 Receptor Antagonist

In Vitro Pharmacological Profile of a New Small Molecule Bradykinin B2 Receptor AntagonistGPCR Target: Calcium assayAuthors: Anne Lesage, et al.Company: Pharvaris Netherlands B.V., Leiden, NetherlandsJournal: Frontiers in Pharmacology. June 19,…

Continue ReadingIn Vitro Pharmacological Profile of a New Small Molecule Bradykinin B2 Receptor Antagonist

A novel luminescence-based β-arrestin membrane recruitment assay for unmodified GPCRs

A novel luminescence-based β-arrestin membrane recruitment assay for unmodified GPCRs GPCR Target: μ/κ/d/Nociceptin Authors: Maria Hauge Pedersen,  et al. Company: Columbia University, New York Journal: Journal of Biological Chemistry, Volume…

Continue ReadingA novel luminescence-based β-arrestin membrane recruitment assay for unmodified GPCRs

GPR37L1 modulates seizure susceptibility: Evidence from mouse studies and analyses of a human GPR37L1 variant

GPR37L1 modulates seizure susceptibility: Evidence from mouse studies and analyses of a human GPR37L1 variantGPCR Target: GPR37L1Authors: Michelle M.Giddensa, et al.Company: Emory University School of Medicine / Children's Mercy HospitalJournal:…

Continue ReadingGPR37L1 modulates seizure susceptibility: Evidence from mouse studies and analyses of a human GPR37L1 variant

Chapter Two – Potential Use of G Protein-Coupled Receptor-Blocking Monoclonal Antibodies as Therapeutic Agents for Cancers

Chapter Two - Potential Use of G Protein-Coupled Receptor-Blocking Monoclonal Antibodies as Therapeutic Agents for CancersAuthor: Deron R.HerrCompany: Expression Drug DesignsJournal: International Review of Cell and Molecular Biology Volume 297,…

Continue ReadingChapter Two – Potential Use of G Protein-Coupled Receptor-Blocking Monoclonal Antibodies as Therapeutic Agents for Cancers

Anticonvulsant Met-Enkephalin Analogues Containing Backbone Spacers Reveal Alternative Non-Opioid Signaling in the Brain

Anticonvulsant Met-Enkephalin Analogues Containing Backbone Spacers Reveal Alternative Non-Opioid Signaling in the BrainGPCR Target: OpioidAuthors: Hee-Kyoung Lee, et al.Company: The University of Utah / The Walter and Eliza Hall Institute…

Continue ReadingAnticonvulsant Met-Enkephalin Analogues Containing Backbone Spacers Reveal Alternative Non-Opioid Signaling in the Brain